Safety outcomes encompassed treatment-emergent and serious adverse events, the presence of anti-cagrilintide antibodies, and changes in blood pressure, pulse rate, high-sensitivity C-reactive protein, plasma renin activity, and aldosterone levels
Heres how they compare, molecule to molecule
ALF is marked by significant changes in liver function, presenting symptoms such as encephalopathy, coagulopathy, and jaundice in individuals who do not have preexisting chronic liver disease
doi: 10.1016/j.tem.2015.07.001 272 XuLYinYLiYChenXChangYZhangHet al
275 This provides an idea for treating PDAC by targeting the BCAA metabolism of CAF cells in the tumor environment and also proves that the tumor and various cells in the environment communicate with each other as a whole